NIAID/DMID/CASG Central Unit [clinicaltrials_resource:ff3752f884d76e65e0cd28ffc4039b35]
A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections. [clinicaltrials:NCT00001100]A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome [clinicaltrials:NCT00001123]Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) [clinicaltrials:NCT00001126]
location [clinicaltrials_vocabulary:location]
NIAID/DMID/CASG Central Unit [clinicaltrials_resource:ff3752f884d76e65e0cd28ffc4039b35]
Bio2RDF identifier
ff3752f884d76e65e0cd28ffc4039b35
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ff3752f884d76e65e0cd28ffc4039b35
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:ff3752f884d76e65e0cd28ffc4039b35
title
NIAID/DMID/CASG Central Unit
@en
type
label
NIAID/DMID/CASG Central Unit [clinicaltrials_resource:ff3752f884d76e65e0cd28ffc4039b35]
@en